- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
After Double-Digit Percentage Declines, Are Vaccine Stocks Buys?
August 30, 2022
From Motley Fool
US Stock Futures Higher Ahead Of Economic Data, Fed Speakers
August 30, 2022
From Benzinga
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report
August 30, 2022
From Benzinga
Could This Move by Moderna Cost Pfizer Billions?
August 28, 2022
From Motley Fool
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
From Benzinga
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany
August 26, 2022
From MarketWatch
From Benzinga
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
August 26, 2022
From Benzinga
From Benzinga
Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
August 24, 2022
From MarketWatch
Here's Why This Dominant Income Stock Is a Buy
August 24, 2022
From Motley Fool
From MarketWatch
Pfizer and BioNTech say data shows COVID vaccine has more than 70% efficacy in small children, and cases now rising in just 7 states
August 23, 2022
From MarketWatch
Pfizer/BioNTech's COVID-19 Vaccine Updated Data Shows Around 76% Efficacy In Toddlers
August 23, 2022
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
From Benzinga
Boosters Are Coming For Dangerous Omicron COVID-19 Variant. Here's Who May Be Rolling Them Out
August 22, 2022
From Benzinga
From Benzinga
Jill Biden leaves isolation after twice testing negative and Novavax vaccine allowed for teens
August 22, 2022
From MarketWatch
From Benzinga
Canada OKs Pfizer COVID-19 Booster For Kids Aged 5-11 Years
August 22, 2022
From Benzinga
The Rise and Fall of Novavax
August 21, 2022
From Motley Fool
What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out
August 19, 2022
From MarketWatch
Large-scale study finds COVID patients at higher risk of brain fog and psychosis after two years compared with other respiratory illnesses
August 18, 2022
From MarketWatch
From Benzinga
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
August 17, 2022
From InvestorPlace
A Look Into Healthcare Sector Value Stocks
August 15, 2022
From Benzinga
U.K. regulator is first to authorize Moderna’s bivalent COVID booster for adults aged 18 and older
August 15, 2022
From MarketWatch
1 Hot Growth Stock to Buy, and 1 to Avoid (For Now)
August 15, 2022
From Motley Fool
Landmark Drug Pricing Reform Bill Passes Congress House
August 15, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.